We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002736:SZSEGuosen Securities Co., Ltd. Class A Analysis

Data as of 2026-06-12 - not real-time

CN¥10.27

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Guosen Securities trades at CNY 10.27, well below its DCF‑derived fair value of roughly CNY 27.7, implying over 100% upside. The stock’s valuation metrics reinforce this gap: a trailing P/E of 10.5 versus an industry average of 16.8, and a price‑to‑book of just 1.05. Dividend yield remains attractive at 4.38% with a payout ratio under 50%, supported by solid operating cash flow and a net cash position that exceeds total debt. Technically, the price sits above the 20‑day SMA (10.11) but below the 50‑day (10.78) and 200‑day (12.64) averages, indicating a short‑term bearish bias; however, the MACD histogram has turned positive and the RSI is neutral, suggesting emerging buying pressure near the current support of CNY 9.79.
The broader market sentiment is in “Extreme Greed” territory, yet the stock’s volatility (≈21% over 30 days) and low beta (≈0.43) temper downside risk. With stable trading volumes and a market cap of over CNY 100 bn, liquidity is solid. Overall, the combination of deep valuation discount, robust dividend, and improving technical momentum positions Guosen Securities as a compelling value play, especially for investors comfortable with moderate sector and regulatory exposure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering near support with limited upside to CNY 10.5 resistance
  • Bullish MACD histogram indicating early momentum shift
  • High dividend yield providing immediate income

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF valuation suggests >100% upside
  • Strong cash position and manageable debt levels
  • Attractive dividend yield with sustainable payout

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Persistently low valuation multiples relative to peers
  • Stable earnings base and consistent dividend policy
  • Potential industry consolidation favoring well‑capitalized securities firms

Key Metrics & Analysis

Financial Health

Revenue Growth-4.50%
Profit Margin45.47%
P/E Ratio10.5
ROE8.32%
ROA1.97%
Debt/Equity193.19
P/B Ratio1.0
Op. Cash FlowCN¥21.8B
Industry P/E16.8

Technical Analysis

TrendBearish
RSI48.5
SupportCN¥9.79
ResistanceCN¥10.50
MA 20CN¥10.11
MA 50CN¥10.78
MA 200CN¥12.64
MACDBullish
VolumeStable
Fear & Greed Index89.86

Valuation

Fair ValueCN¥27.69
Target PriceCN¥21.00
Upside/Downside104.48%
GradeUndervalued
TypeValue
Dividend Yield4.38%

Risk Assessment

Beta0.43
Volatility20.97%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.